AB-BIOTICS exhibits at Vitafoods Europe 2021 with Dipro probiotics 28 October 2021 – 2 min read Vitafoods Europe 2021 took place in Geneva the past… Read More »AB-BIOTICS exhibits at Vitafoods Europe 2021 with Dipro probiotics
After cancellation in 2020, Vitafoods Europe comes back this year as a hybrid event. The in-person congress will take place from the 5th to 7th of October in Geneva, reuniting professionals of the nutraceutical world. We are excited to participate once again in an event that will help reinforce connections between industry members and impulse networking.
Frontiers has published the latest clinical data of AB-KOLICARE™, that shows quite promising results on infant colic. This probiotic formulation leads AB-BIOTICS pediatric line, containing two bacteria strains with a battery of benefits for babies.
AB21 breakthrough clinical results have caught the attention of Nicholas Hall, that has presented the probiotic formulation as Innovation of the month.
Next Sunday 27th of June is World Microbiome Day. This event was founded in 2019 as an initiative to increase awareness of the microbiota, and unite all researchers and companies interested on the subject.
The 8th International Human Microbiome Consortium Congress (IHMC) is a major scientific event with the aim to to provide a better understanding about human microbiome. This year, it will be developed in a 100% digital format from 27 th to 29th of June, since fully digital format will allow to attract a large international audience and scientific community.
Microbiome science keeps expanding and evolving at an accelerated rate. Scientists, healthcare professionals and consumers are progressively more aware of the microbiota, and how its modulation can have a beneficial impact on health status.
Kemiex is a revolutionary digital platform that allows to connect global suppliers with clients that are looking for raw materials. Main users are companies from Feed, Food, Vet and Pharma industries that are looking to sell or buy ingredients.
Last 8th of April, the third scientific-practical conference dedicated to the memory of V.V.Murashko took place in Moscow, Russia. The program contained extended lectures around lipidology, cardiology, gastroenterology and gerontology
Irritable bowel syndrome (IBS) is a very common functional gastrointestinal disorder that affects around 580 million people worldwide. It is a major women’s health issue since 2 out of 3 individuals who report IBS in the community are female.
The latest consensus guidelines (Rome IV) define IBS as: “A gut-brain disorder characterized by recurrent abdominal pain associated to changes in frequency or appearance of stools at least 1 day per week for the last 3 months” 1
IBS symptoms include abdominal pain, discomfort , bloating or distension and gut-specific anxiety.
All these features interfere with the daily life of many patients, having a significant detrimental effect in their quality of life.